Novartis AG (NVS)
NYSE: NVS · IEX Real-Time Price · USD
102.84
+0.27 (0.26%)
May 20, 2024, 4:00 PM EDT - Market closed
Novartis AG Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Novartis AG stock have an average target of 115, with a low estimate of 114 and a high estimate of 116. The average target predicts an increase of 11.82% from the current stock price of 102.84.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Novartis AG stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 2 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
BMO Capital | BMO Capital | Hold Maintains $114 → $116 | Hold | Maintains | $114 → $116 | +12.80% | Apr 24, 2024 |
BMO Capital | BMO Capital | Hold Initiates $114 | Hold | Initiates | $114 | +10.85% | Feb 23, 2024 |
Morgan Stanley | Morgan Stanley | Hold Initiates $114 | Hold | Initiates | $114 | +10.85% | Jan 23, 2024 |
Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Sep 25, 2023 |
Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 9, 2022 |
Financial Forecast
Revenue This Year
49.09B
from 46.66B
Increased by 5.20%
Revenue Next Year
51.06B
from 49.09B
Increased by 4.02%
EPS This Year
7.19
from 7.10
Increased by 1.23%
EPS Next Year
7.90
from 7.19
Increased by 9.92%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 51.9B | 54.3B | 56.5B | 57.1B | 59.7B |
Avg | 49.1B | 51.1B | 51.7B | 52.6B | 54.1B |
Low | 46.1B | 46.8B | 47.1B | 46.8B | 47.8B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 11.3% | 10.7% | 10.7% | 10.4% | 13.5% |
Avg | 5.2% | 4.0% | 1.3% | 1.8% | 2.8% |
Low | -1.2% | -4.7% | -7.7% | -9.4% | -9.3% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 8.52 | 8.94 | 9.89 | 9.88 | 10.54 |
Avg | 7.19 | 7.90 | 8.36 | 8.75 | 9.40 |
Low | 5.06 | 5.41 | 7.12 | 7.21 | 8.29 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 20.0% | 24.4% | 25.2% | 18.2% | 20.4% |
Avg | 1.2% | 9.9% | 5.8% | 4.7% | 7.3% |
Low | -28.8% | -24.7% | -9.8% | -13.7% | -5.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.